Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Voriconazole | 2 | 2019 | 206 | 1.30 | Why? |
Pulmonary Aspergillosis | 4 | 2019 | 408 | 1.25 | Why? |
Antifungal Agents | 6 | 2019 | 1828 | 1.21 | Why? |
Aspergillosis | 3 | 2018 | 264 | 1.14 | Why? |
AIDS-Related Opportunistic Infections | 3 | 2021 | 260 | 0.97 | Why? |
Hyperphagia | 1 | 2021 | 64 | 0.89 | Why? |
Triazoles | 3 | 2019 | 440 | 0.82 | Why? |
Aspergillus nidulans | 1 | 2018 | 2 | 0.79 | Why? |
Consensus Development Conferences as Topic | 1 | 2019 | 93 | 0.78 | Why? |
Aspergillus flavus | 1 | 2018 | 51 | 0.75 | Why? |
Aspergillus | 3 | 2018 | 347 | 0.73 | Why? |
Contraceptive Agents | 1 | 2018 | 62 | 0.70 | Why? |
Onychomycosis | 1 | 2017 | 23 | 0.70 | Why? |
Cryptococcus neoformans | 1 | 2018 | 71 | 0.68 | Why? |
Diagnostic Techniques and Procedures | 1 | 2019 | 265 | 0.66 | Why? |
Fluconazole | 1 | 2018 | 145 | 0.66 | Why? |
Itraconazole | 1 | 2018 | 135 | 0.65 | Why? |
Cryptococcosis | 1 | 2018 | 97 | 0.65 | Why? |
Drug Resistance, Fungal | 1 | 2018 | 191 | 0.62 | Why? |
Weight Gain | 1 | 2021 | 552 | 0.62 | Why? |
Uganda | 4 | 2021 | 1057 | 0.62 | Why? |
Mycoses | 2 | 2021 | 589 | 0.62 | Why? |
Aspergillus fumigatus | 1 | 2018 | 239 | 0.62 | Why? |
Nitriles | 1 | 2019 | 1053 | 0.52 | Why? |
Acquired Immunodeficiency Syndrome | 1 | 2019 | 533 | 0.50 | Why? |
Pyridines | 1 | 2019 | 680 | 0.49 | Why? |
Hospitals, Teaching | 1 | 2020 | 1609 | 0.46 | Why? |
Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.39 | Why? |
Drug-Related Side Effects and Adverse Reactions | 2 | 2019 | 1261 | 0.39 | Why? |
Hospitals, University | 1 | 2020 | 4173 | 0.34 | Why? |
Health Knowledge, Attitudes, Practice | 2 | 2020 | 8811 | 0.33 | Why? |
Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.25 | Why? |
Students, Medical | 1 | 2020 | 4032 | 0.21 | Why? |
Genes, Fungal | 1 | 2018 | 21 | 0.19 | Why? |
Microbial Sensitivity Tests | 2 | 2018 | 2886 | 0.19 | Why? |
Contraception Behavior | 1 | 2018 | 60 | 0.18 | Why? |
Quality of Life | 2 | 2018 | 9820 | 0.17 | Why? |
Meningitis, Cryptococcal | 1 | 2018 | 79 | 0.17 | Why? |
Amphotericin B | 1 | 2018 | 256 | 0.17 | Why? |
Genetic Loci | 1 | 2018 | 439 | 0.16 | Why? |
Chronic Disease | 4 | 2019 | 5139 | 0.16 | Why? |
Neglected Diseases | 1 | 2021 | 381 | 0.15 | Why? |
Surveys and Questionnaires | 2 | 2020 | 43792 | 0.15 | Why? |
Microbiological Techniques | 1 | 2017 | 232 | 0.15 | Why? |
Microscopy | 1 | 2017 | 414 | 0.13 | Why? |
HIV Infections | 2 | 2021 | 11620 | 0.13 | Why? |
Schools, Medical | 1 | 2020 | 793 | 0.12 | Why? |
Body Weight | 1 | 2018 | 1074 | 0.11 | Why? |
Prevalence | 3 | 2018 | 25773 | 0.11 | Why? |
Sputum | 1 | 2018 | 1720 | 0.10 | Why? |
Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
Adult | 7 | 2021 | 244371 | 0.09 | Why? |
Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
Cross-Sectional Studies | 3 | 2020 | 53120 | 0.09 | Why? |
Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.09 | Why? |
Diagnosis, Differential | 1 | 2021 | 7220 | 0.08 | Why? |
International Cooperation | 1 | 2019 | 3436 | 0.07 | Why? |
Humans | 14 | 2021 | 930598 | 0.07 | Why? |
Female | 7 | 2021 | 380317 | 0.07 | Why? |
Retrospective Studies | 4 | 2019 | 105322 | 0.06 | Why? |
Young Adult | 3 | 2020 | 93724 | 0.06 | Why? |
Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
Ambulatory Care | 1 | 2018 | 4947 | 0.05 | Why? |
Male | 6 | 2020 | 367725 | 0.05 | Why? |
Aged, 80 and over | 3 | 2019 | 88759 | 0.05 | Why? |
Adolescent | 2 | 2020 | 86841 | 0.05 | Why? |
United Kingdom | 1 | 2019 | 18046 | 0.04 | Why? |
Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
Middle Aged | 4 | 2019 | 270681 | 0.04 | Why? |
Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
Aged | 4 | 2019 | 215776 | 0.03 | Why? |
Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
Immunoglobulin G | 1 | 2018 | 21571 | 0.03 | Why? |
Pandemics | 1 | 2020 | 389249 | 0.03 | Why? |
Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
Risk Factors | 1 | 2017 | 71621 | 0.02 | Why? |
Outpatients | 1 | 2018 | 3417 | 0.02 | Why? |
Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
Bongomin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(83)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(60)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_